George Elston | Chief Financial Officer and Head-Corporate Development |
Nancy Lurker | President and Chief Executive Officer |
Scott Jones | Chief Commercial Officer |
Dario Paggiarino | Senior Vice President and Chief Medical Officer |
Dana Flanders | Guggenheim Securities |
Andrew D'Silva | B. Riley FBR |
I-Eh Jen | Laidlaw & Company |
Yi Chen | H.C. Wainwright |
Good morning. My name is Sarah and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2019 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company’s request.